Story March 6 - Atea Pharmaceuticals: After giving up on its COVID ambitions last year, Atea revealed in its annual financial results that during the first quarter of 2025, the biotech has slashed ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果